Cancer blood test may detect recurrence early

Cancer blood test may detect recurrence early

| Jan 11, 2021 | Medical Malpractice |

When a patient has cancer, time is of the essence in all parts of the process. For those in Texas who go undiagnosed or receive a misdiagnosis, the results can be catastrophic, as cancer may go unchecked and be more difficult to treat once finally discovered. This type of negligence is often grounds for a medical malpractice claim, as patients will surely have a diminished quality of life. Fortunately, new research shows that a blood test may help detect a recurrence of cancer for many patients and the medical industry is hopeful for its potential to save lives.

The oncologist who developed the test reports that it detects the presence of tumor DNA in the bloodstream, which can happen with certain cancers. Since different mutations can happen with different types of tumors, the test can be modified to detect those specific mutations. For patients concerned about cost, coverage is now available through Medicare and many insurance providers. Other doctors are a bit reluctant saying that more information is needed before using the test as a guideline for treatment.

One patient who has been using the test for several years reports that his cancer has not come back. He originally had his colon cancer misdiagnosed, and he says his whole cancer journey took a lot out of him. He is confident that the test will detect any recurrence early and give him options for treatment he may not have had initially.

Though this blood test seems promising, the reality for many people with cancer is that misdiagnosis will still happen and may have a severe impact upon their lives. Many Texas families may want to file a medical malpractice claim after a provider fails to issue a diagnosis in accordance with a traditional standard of care. Those who are unsure whether this option is available to them can speak with a personal injury attorney to determine possible action to take.